======= MICAL2 ======= == Gene Information == * **Official Symbol**: MICAL2 * **Official Name**: microtubule associated monooxygenase, calponin and LIM domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9645|9645]] * **UniProt**: [[https://www.uniprot.org/uniprot/O94851|O94851]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MICAL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MICAL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608881|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a monooxygenase that enhances depolymerization of F-actin and is therefore involved in cytoskeletal dynamics. The encoded protein is a regulator of the SRF signaling pathway. Increased expression of this gene has been associated with cancer progression and metastasis. [provided by RefSeq, Oct 2016]. * **UniProt Summary**: Nuclear monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization. In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2) (By similarity). Acts as a key regulator of the SRF signaling pathway elicited by nerve growth factor and serum: mediates oxidation and subsequent depolymerization of nuclear actin, leading to increase MKL1/MRTF-A presence in the nucleus and promote SRF:MKL1/MRTF-A- dependent gene transcription. Does not activate SRF:MKL1/MRTF-A through RhoA. {ECO:0000250|UniProtKB:Q8BML1, ECO:0000250|UniProtKB:Q8TDZ2, ECO:0000269|PubMed:24440334}. |LIM| |Pyr redox 2| |FAD binding 3| |CH| |CAMSAP CH| |FAD binding 2| |NADPH:sulfur oxidoreductase activity| |sulfur oxidation| |positive regulation of transcription via serum response element binding| |NAD(P)H oxidase activity| |actin filament depolymerization| |oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen| |FAD binding| |protein depolymerization| |actin polymerization or depolymerization| |heart looping| |embryonic heart tube morphogenesis| |determination of heart left/right asymmetry| |embryonic heart tube development| |determination of left/right symmetry| |oxidoreductase activity| |determination of bilateral symmetry| |specification of symmetry| |cellular protein complex disassembly| |protein-containing complex disassembly| |actin filament organization| |heart morphogenesis| |actin binding| |embryonic organ morphogenesis| |epithelial tube morphogenesis| |sulfur compound metabolic process| |cellular component disassembly| |morphogenesis of an epithelium| |embryonic organ development| |pattern specification process| |supramolecular fiber organization| |actin cytoskeleton organization| |heart development| |tissue morphogenesis| |embryonic morphogenesis| |actin filament-based process| |tube morphogenesis| |tube development| |circulatory system development| |animal organ morphogenesis| |oxidation-reduction process| |embryo development| |cytoskeleton organization| |epithelium development| |positive regulation of transcription by RNA polymerase II| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-2.13| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.86| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6279 * **Expression level (log2 read counts)**: 2.84 {{:chemogenomics:nalm6 dist.png?nolink |}}